Dáil Éireann Debate, Tuesday - 17 January 2017
890. Deputy Pearse Doherty asked the Minister for Health if wearable flash sensor monitoring technology for the purpose of blood glucose monitoring and glucose testing is available through the long-term illness scheme; if not, his plans to include the device as part of the scheme; and if he will make a statement on the matter. [41244/16]
Amharc ar fhreagra1298. Deputy Louise O'Reilly asked the Minister for Health if his attention has been drawn to developments in the management of type 1 diabetes which eliminate the need for finger prick tests in place of a new blood glucose monitoring system using skin sensors; if he will consider the inclusion of this new blood glucose monitoring system using skin sensors on the long-term illness scheme; and if he will make a statement on the matter. [1591/17]
Amharc ar fhreagraI propose to take Questions Nos. 890 and 1298 together.
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal devices under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
